decision, Syneos Health stockholders are urged to read the proxy statement in its entirety, when it becomes available, and any other documents to be filed with the SEC in connection with the
proposed transaction or incorporated by reference in the proxy statement (including any amendments or supplements to these documents), if any, because they will contain important information about the proposed transaction and the parties to the
proposed transaction. This communication is not a substitute for the proxy statement or any other document that may be filed by Syneos Health with the SEC.
Syneos Health investors and stockholders may obtain a free copy of the proxy statement and documents filed by Syneos Health with the SEC at the SECs
website at www.sec.gov. In addition, Syneos Health investors and stockholders may obtain a free copy of Syneos Healths filings with the SEC from Syneos Healths website at investor.syneoshealth.com or by directing a request by mail to
1030 Sync Street, Morrisville, NC 27560 or telephone to (919) 876-9300.
Participants in the Solicitation
Syneos Health and its directors and executive officers and other members of management and employees may, under the rules of the SEC, be deemed to be
participants in the solicitation of proxies from the stockholders of Syneos Health in respect of the proposed transactions contemplated by the proxy statement. Information regarding Syneos Healths directors and executive officers is contained
in Syneos Healths Annual Report on Form 10-K/A for the year ended December 31, 2022, filed with the SEC on May 1, 2023 (the Form 10-K/A), and
in the proxy statement for Syneos Healths 2022 annual meeting of stockholders on Schedule 14A, filed with the SEC on April 12, 2022. Additional information regarding the persons who are, under the rules of the SEC, participants in the
solicitation of the stockholders of Syneos Health in connection with the proposed transactions, including a description of their direct or indirect interests, by security holdings or otherwise, will be set forth in the proxy statement when it is
filed with the SEC, free copies of which may be obtained as described in the preceding paragraph. To the extent holdings of Syneos Healths securities by Syneos Healths directors and executive officers change from the amounts set forth in
the Syneos Health Form 10-K/A or in the proxy statement, such changes have been or will be reflected on Statements of Change in Ownership on Form 4 filed with the SEC.
Forward-Looking Statements
Any assumptions, views or
opinions (including statements, projections, forecasts or other forward-looking statements) contained in this communication represent the assumptions, views or opinions of Syneos Health, unless otherwise indicated, as of the date indicated and are
subject to change without notice. All information not separately sourced is from internal company data and estimates. Any data relating to past performance contained herein is no indication as to future performance. The information in this
communication is not intended to predict actual results, and no assurances are given with respect thereto.
The information contained in this
communication has not been independently verified, and no representation or warranty, express or implied, is made as to the fairness, accuracy, completeness or correctness of the information contained herein and no reliance should be placed on it.
None of Syneos Health or any of its affiliates, advisers, affiliated persons or any other person accept any liability for any loss howsoever arising (in negligence or otherwise), directly or indirectly, from this communication or its contents or
otherwise arising in connection with this communication. This shall not, however, restrict or exclude or limit any duty or liability to a person under any applicable law or regulation of any jurisdiction which may not lawfully be disclaimed
(including in relation to fraudulent misrepresentation).
|
|
|
|
|
|
|
© 2023 All rights reserved | Confidential | For Syneos Health® use only |
|
2 |